The Insuridge temperature-controlled shipping container is an innovative alternative to traditional passive shippers that rely on dry ice or phase-change materials. Utilizing advanced semiconductor technology, the Insuridge container ensures the safe transportation of temperature-sensitive materials, such as DNA, RNA, intact cells, and pharmaceuticals.
"We are thrilled to partner with Senpex and provide them with our cutting-edge Insuridge shipping containers," said Faizan Ahmed, CEO and Founder of Invensify. "Our solution aligns perfectly with Senpex's commitment to embracing advanced technologies and improving the reliability of their courier services. Together, we are transforming the last-mile delivery of temperature-sensitive pharmaceuticals, ensuring the integrity and safety of these critical products."
Senpex, with a proven track record of over 500,000 successful deliveries since its inception in 2017, offers a wide range of courier and logistics services across various industries. By incorporating Invensify's Insuridge shipping containers, Senpex aims to better address the challenges of maintaining cold chain integrity during deliveries.
"Senpex has always prioritized the adoption of innovative technology to enhance our courier service and streamline operations," said Anar Mammadov, CEO and co-founder of Senpex Technology. "Partnering with Invensify to provide FDA 21 CFR compliant tracking and monitoring of temperature-sensitive pharmaceutical shipments was a natural decision. We believe this collaboration will significantly contribute to our mission of delivering affordable, convenient, and trusted shipping services to industries of all sizes."
Related tags: cold chain